[1]
E. . Radu, “The Role of NLRP3 Inflammasome in the Pathogenesis and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease”, CRMS, vol. 5, no. 4, pp. 12–19, Sep. 2026.